HOME >> MEDICINE >> NEWS
Statin drugs may lower risk of Alzheimers

DENVER, CO Taking the cholesterol-lowering drugs called statins may reduce the risk of developing Alzheimers disease, according to research presented during the American Academy of Neurologys 54th Annual Meeting in Denver, Colo., April 13-20, 2002.

The study found that taking statins was associated with a 79-percent reduction in the risk of developing Alzheimers disease, according to the studys lead author, neurologist and epidemiologist Robert C. Green, MD, MPH, of Boston University School of Medicine.

This study confirms and extends previous reports and is the largest study on this topic in the U.S., Green said. It is also the first to include a large number of African-American families.

Researchers studied 2,581 people from more than 800 families, enrolled over six years at 15 medical centers. They examined risk factors and medication history in 912 people with probable or definite Alzheimers disease and 1,669 of their family members who did not have dementia. The results were adjusted for age, sex, education, and history of heart disease, stroke and diabetes.

The relationship between statins and risk of Alzheimers was no different for people with the gene variant associated with an increased risk of Alzheimers, apolipoprotein E ?4, or apoE-?4. The relationship between statins and Alzheimers was also the same for whites as it was for African Americans, who have a higher risk of developing the disease.

Statins lower levels of low-density lipoprotein (LDL) cholesterol by blocking the production of a liver enzyme used by the body to make cholesterol. In this study, cholesterol-lowering drugs other than statins were not associated with a reduced risk of Alzheimers. There was also no difference between the use of natural and synthetic statins.


'"/>

Contact: Cheryl Alementi
calementi@aan.com
651-695-2737
American Academy of Neurology
16-Apr-2002


Page: 1

Related medicine news :

1. Statins effective in long term, Nordic study suggests
2. Statins show early promise for treating multiple sclerosis
3. Statins and aspirin may protect against severe vision loss in elderly
4. Statins could reduce stroke risk by a third
5. Statin drugs may help patients with heart valve disease avoid surgery
6. Statin drugs lower heart disease risk in postmenopausal women
7. Statin drugs may increase risk of peripheral neuropathy
8. Statins may inhibit calcium growth on aortic valve in the elderly
9. People Who Are Diabetic And Glucose Intolerant Can Benefit From "Statin" Drug Therapy, Even If Cholesterol Levels Are Normal
10. International Study Finds Statins Raise Good Cholesterol, Wake Forest Physician Reports
11. Studies Look At Threshold Effect Of Cholesterol-Lowering "Statin" Drugs

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Statin drugs may lower risk Alzheimers

(Date:3/27/2015)... 27, 2015 Operatic contenders and their ... on April 17th. The universally acclaimed baritone Sherrill Milnes ... annual Opera Idol at The Merion in Evanston. The ... has drawn aspiring opera singers from around the country. ... of the finest young talent in the country,” said ...
(Date:3/27/2015)... MN (PRWEB) March 27, 2015 ... Minnesotans for Healthy Kids Coalition Lobby Day to ... Statewide Health Improvement Program (SHIP). Everlast Climbing ... 2015 PE Bill SF343/HF498 which would strengthen physical ... annual student assessments and other measures to strengthen ...
(Date:3/27/2015)... Jersey (PRWEB) March 27, 2015 Airy ... has released the official music video for her debut ... , Combining live-action and abstract styling effects, the ... be viewed on YouTube, Vimeo, and assorted outlets. It ... the development of an expanding full-scale marketing strategy. The ...
(Date:3/27/2015)... April 2015 is the 150th anniversary of the ... America’s bloodiest war and the amazing President that led our ... to the Civil War and Abraham Lincoln. This moving event ... the Jane Pickens Theater in Newport, RI. , Chief ... as the master of ceremonies. Dr. Fred Zilian, educator, writer ...
(Date:3/27/2015)... 27, 2015 The Florida Center for ... Cancer Cure (ABC2), awarded $350,000 to support brain cancer ... The Scripps Research Institute and H. Lee Moffitt Cancer ... with a clear development path and potential to provide ... near future. , The awards fund research in ...
Breaking Medicine News(10 mins):Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Everlast Climbing Advocates to Strengthen Physical Education in Minnesota Schools 2Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3
(Date:3/27/2015)... --  Hospira, Inc. (NYSE: HSP ), ... leading provider of injectable drugs and infusion technologies, ... biosimilarity of its proposed biosimilar, Epoetin Hospira, with ... approved name of RETACRIT™, compared to the reference ... were presented at the National Kidney Foundation (NKF) ...
(Date:3/27/2015)... , March 27, 2015  Delcath Systems, ... and medical device company focused on oncology with ... metastatic liver cancers, announces the reporting of data ... Melphalan Hydrochloride for Injection with the Delcath Hepatic ... poster presentation at the Society of Surgical Oncology ...
(Date:3/26/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or ... on Omega-3 therapies for cardiovascular disease and overall health, ... common shares of the Corporation (the "Common Shares"). The ... of December 5 th , 2014 to March 4 ... is due on or before April 1, 2015. Interest ...
Breaking Medicine Technology:Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 2Hospira Clinical Data Shows Proposed Biosimilar, Epoetin Hospira, Demonstrates Pharmacokinetic And Pharmacodynamic Equivalence Compared To Amgen's Epogen 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 2Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 3Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 4Data Highlighting Delcath's Melphalan/HDS Presented At The Society Of Surgical Oncology Annual Meeting 5Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2
Cached News: